Oncological therapies are among the most complex treatment forms in everyday hospital care. They require precise coordination between prescription, preparation, delivery, documentation, and billing. Manual handovers, heterogeneous systems, and media-disruptive processes not only increase the risk of errors but also consume valuable human resources. MC³ Oncology addresses these challenges with a fully integrated digital system – enhancing patient safety, creating traceable processes, and significantly relieving staff in medical services, pharmacy, and IT.

A modern oncological workflow begins with structured prescribing directly from the electronic chart – including supportive and long-term medications. Therapy planning includes medical plausibility checks and can be seamlessly transferred to preparation. Manufacturing takes place under standardized conditions, optionally gravimetrically and with guided documentation. The prepared application units are then delivered to the ward, where they are administered and documented in the chart on a patient-specific basis. Billing data is generated automatically and in compliance with regulations. This end-to-end digital process provides all stakeholders with reliable data and control over the entire treatment chain – without system disruptions or redundancies.

Mesalvo’s oncology solution MC³ Oncology integrates all steps of drug-based tumor therapy into a single system landscape. Medical prescriptions are made directly from the digital chart – including medication safety (AMTS) checks across chemotherapy, supportive, and long-term medications. Preparation can be supported gravimetrically; dose adjustments are automatically transferred back to the chart. AI-supported camera systems enable visual validation of the manufacturing process – such as batch recognition or volume control. Billing is system-assisted and based on the documented procedures, while administration is fully recorded in the chart – together with the rest of the patient’s medication.